Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Avista Public Acquisition Corp. II (AHPAU)

10.12   0 (0%) 01-19 08:02
Open: 10.1101 Pre. Close: 10.12
High: 10.12 Low: 10.1101
Volume: 301 Market Cap: 0M
Avista Public Acquisition Corp. II intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing businesses in the healthcare industry. The company was incorporated in 2021 and is based in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 10.134 - 10.191 10.191 - 10.243
Low: 9.956 - 10.032 10.032 - 10.102
Close: 10.011 - 10.12 10.12 - 10.22

Technical analysis

as of: 2022-01-18 4:29:14 PM
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 11.87     One year: 11.91
Support: Support1: 10.11    Support2: 8.41
Resistance: Resistance1: 10.17    Resistance2: 10.20
Pivot: 10.13
Moving Average: MA(5): 10.14     MA(20): 10.14
MA(100): 10.13     MA(250):
MACD: MACD(12,26):     Signal(9):
Stochastic oscillator: %K(14,3): 25.00     %D(3): 35.65
RSI: RSI(14): 41.34
52-week: High: 10.59  Low: 10.00  Change(%): 1.2
Average Vol(K): 3-Month: 1890  10-Days: 75

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
AHPAU has closed above bottom band by 29.8%. Bollinger Bands are 0% narrower than normal.

Headline News

Mon, 27 Sep 2021
Avista Public Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing September 30, 2021 - PRNewswire

Tue, 10 Aug 2021
Biopharma firm Eliem Therapeutics' stock set to start trading after IPO prices weakly - Seeking Alpha

Mon, 09 Aug 2021
Avista Public Acquisition Corp. II Announces Pricing of $200 Million Initial Public Offering - PRNewswire

Thu, 17 Jun 2021
Healthcare-focused SPAC Avista Public Acquisition II files for a $200 million IPO - Renaissance Capital

Wed, 31 Dec 1969

Wed, 31 Dec 1969

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Industrials
Industry:  Shell Companies
Shares Out. (M)
Shares Float (M)
% Held by Insiders
% Held by Institutions 91.09
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -0.240
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value -42.17
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.